ABL Bio에이비엘바이오

ABL Bio298380· Biotech & PharmaInitiation

ABL Bio: Loss-making KOSDAQ biotech with shares down 51.4% over one year

ABL Bio closed at ₩45,600 on 2026-10-12, near its 52-week low of ₩45,350 and well below the high of ₩257,500, with a market cap of about ₩2.2T. Filed statements show trailing revenue of ₩34.3B against an operating loss of ₩86.1B, so the valuation rests on future outcomes rather than current earnings.

Oct 13, 20260 views